Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD55 Antikörper (AA 35-126)

Der Kaninchen Polyklonal Anti-CD55-Antikörper wurde für IHC, IF und ELISA validiert. Er ist geeignet, CD55 in Proben von Human zu detektieren.
Produktnummer ABIN7148376

Kurzübersicht für CD55 Antikörper (AA 35-126) (ABIN7148376)

Target

Alle CD55 Antikörper anzeigen
CD55 (Complement Decay-Accelerating Factor (CD55))

Reaktivität

  • 144
  • 32
  • 8
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
Human

Wirt

  • 101
  • 71
  • 6
  • 5
  • 2
  • 1
  • 1
  • 1
Kaninchen

Klonalität

  • 121
  • 65
  • 2
Polyklonal

Konjugat

  • 99
  • 16
  • 16
  • 11
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CD55 Antikörper ist unkonjugiert

Applikation

  • 107
  • 99
  • 45
  • 44
  • 35
  • 26
  • 25
  • 25
  • 17
  • 14
  • 14
  • 4
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA
  • Bindungsspezifität

    • 15
    • 9
    • 8
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 35-126

    Kreuzreaktivität

    Human

    Aufreinigung

    >95%, Protein G purified

    Immunogen

    Recombinant Human Complement decay-accelerating factor protein (35-126AA)

    Isotyp

    IgG
  • Applikationshinweise

    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    CD55 (Complement Decay-Accelerating Factor (CD55))

    Andere Bezeichnung

    CD55

    Hintergrund

    Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.

    Aliases: CD 55 antibody, CD55 antibody, CD55 antigen antibody, CD55 Cromer blood group system antibody, CD55 Molecule (Cromer blood group) antibody, CD55 Molecule antibody, CD55 Molecule, decay accelerating factor for complement (Cromer blood group) antibody, Cd55a antibody, Complement decay accelerating factor antibody, Complement decay-accelerating factor antibody, Complement decay-accelerating factor, GPI-anchored antibody, CR antibody, CROM antibody, Cromer Blood Group antigen antibody, Cromer blood group system antibody, DAF antibody, Daf-GPI antibody, DAF_HUMAN antibody, Daf1 antibody, Dcay accelerating factor for complement (CD55, Cromer blood group system) antibody, Decay accelarating factor 1, isoform CRA_a antibody, Decay accelerating factor (GPI-form) antibody, Decay Accelerating Factor for Complement antibody, Decay accelerating factor GPI-form antibody, Decay accelerating factor soluble-form antibody, GPI-DAF antibody, TC antibody

    UniProt

    P08174

    Pathways

    Komplementsystem, Regulation of Leukocyte Mediated Immunity
Sie sind hier:
Chat with us!